Pathogenesis of intracellular organisms
Date
2023-12
Authors
Phadke, Kruttika
Major Professor
Advisor
Bellaire, Bryan H
McGill, Jodi
Miller, Cathy
Narasimhan, Balaji
Wannemuehler, Michael
Committee Member
Journal Title
Journal ISSN
Volume Title
Publisher
Altmetrics
Abstract
Intracellular pathogens are responsible for most of the infectious diseases that pose a threat to public health. This dissertation highlights two intracellular pathogens, Burkholderia pseudomallei and SARS-CoV-2, and discusses methods to study and treat them.
Burkholderia pseudomallei causes the disease melioidosis which is predominantly a respiratory disease with a mortality rate as high as 40% if left untreated. A peculiar characteristic of the pathogen is its ability to invade and survive inside host cells protecting it from external antibiotics and the host immune system. This dissertation introduces a polyanhydride nanoparticle-based drug delivery system to increase the efficacy of known drugs against B. pseudomallei. We highlight meropenem and ceftazidime as our lead formulations that when encapsulated in nanoparticles can kill the bacteria more efficiently in vitro and in vivo.
Viral pathogens, such as SARS-CoV-2 are obligate intracellular pathogens that use the host mechanisms to survive and replicate. SARS-CoV-2 first emerged in 2019 and has since evolved and adapted into multiple different variants. This dissertation focuses on 3 variants, namely, Wild type, Omicron and Delta. Studying pathogenesis of these variants helps us understand mechanisms important for viral infection that can be used to develop vaccines and antivirals. Here, we compared pathogenesis of the three variants in 5 cells lines to emphasize the importance of 2 host proteins, ACE2 and TMPRSS2. This study introduces a uniform comparison technique that can be altered as new variants emerge to further understand the evolution of the virus.
COVID-19, the disease caused by SARS-CoV-2, is primarily a respiratory disease, but can also affect other parts of the body such as the brain. The neurological propensity of the virus has been observed in my clinical studies where viral titers and neurological symptoms were associated with COVID-19. In this dissertation we aimed to further investigate this phenomenon by setting up an in vitro model to study viral pathogenesis in the brain. We used human microglial cells (HMC3) that are the first responder to any infection or inflammation in the brain. We compared pathogenesis of 3 variants, Wild type, Omicron and Delta in HMC3 cells which highlighted an evolutionary change that was observed in Omicron and Delta but not in Wild type. These unique characteristic pavs the way for further investigation of SARS-CoV-2 brain infections and the mechanisms behind it.
The two pathogens discussed here, although different, have a lot of commonalities, intracellular pathogenesis being the main one. This dissertation highlights the importance of studying emerging intracellular pathogens in multiple cell culture models to understand the host-pathogen interactions clearly. Additionally, it introduces a polyanhydride nanoparticle-based drug delivery system as an effective strategy against a B. pseudomallei, which can also be used against other intracellular pathogens like SARS-CoV-2.
Series Number
Journal Issue
Is Version Of
Versions
Series
Academic or Administrative Unit
Microbiology
Type
article